TY - JOUR
T1 - Document of revision and updating of medication overuse headache (MOH) Documento de revisión y actualización de la cefalea por uso excesivo de medicación (CUEM)
AU - González-Oria, Carmen
AU - Belvís, Roberto
AU - Cuadrado, María Luz
AU - Díaz-Insa, Samuel
AU - Guerrero-Peral, Ángel Luis
AU - Huerta Villanueva, Mariano
AU - Irimia, Pablo
AU - Lainez Andres, Jose Miguel
AU - Latorre, Germán
AU - Leira, Rogelio
AU - Oterino, Agustín
AU - Pascual Gómez, Julio
AU - Porta-Etessam, Jesús
AU - Pozo-Rosich, Patricia
AU - Sánchez del Río, Margarita
AU - Santos Lasaosa, Sonia
PY - 2021
Y1 - 2021
N2 - Introduction: Medication overuse headache is a secondary headache in which the regular or frequent use of analgesics can increase the frequency of the episodes, causing the transition from episodic to chronic headache. The prevalence of medication overuse headache is approximately 1-2%, with higher rates among women aged 30-50 years and with comorbid psychiatric disorders such as depression or anxiety, or other chronic pain disorders. It is important to be familiar with the management of this disease. To this end, the Spanish Society of Neurology's Headache Study Group has prepared a consensus document addressing this disorder. Development: These guidelines were prepared by a group of neurologists specialising in headache after a systematic literature review and provides consensus recommendations on the proper management and treatment of medication overuse headache. The treatment of medication overuse headache is often complex, and is based on 4 fundamental pillars: education and information about the condition, preventive treatment, discontinuation of the drug being overused, and treatment for withdrawal symptoms. Follow-up of patients at risk of recurrence is important. Conclusions: We hope that this document will be useful in daily clinical practice and that it will update and improve understanding of medication overuse headache management.
AB - Introduction: Medication overuse headache is a secondary headache in which the regular or frequent use of analgesics can increase the frequency of the episodes, causing the transition from episodic to chronic headache. The prevalence of medication overuse headache is approximately 1-2%, with higher rates among women aged 30-50 years and with comorbid psychiatric disorders such as depression or anxiety, or other chronic pain disorders. It is important to be familiar with the management of this disease. To this end, the Spanish Society of Neurology's Headache Study Group has prepared a consensus document addressing this disorder. Development: These guidelines were prepared by a group of neurologists specialising in headache after a systematic literature review and provides consensus recommendations on the proper management and treatment of medication overuse headache. The treatment of medication overuse headache is often complex, and is based on 4 fundamental pillars: education and information about the condition, preventive treatment, discontinuation of the drug being overused, and treatment for withdrawal symptoms. Follow-up of patients at risk of recurrence is important. Conclusions: We hope that this document will be useful in daily clinical practice and that it will update and improve understanding of medication overuse headache management.
KW - Medication overuse headache
KW - Detoxification
KW - Preventive treatment
KW - Triptans
KW - Ergot derivatives
KW - Opioids
UR - https://www.scopus.com/pages/publications/85090481538
U2 - 10.1016/j.nrl.2020.04.029
DO - 10.1016/j.nrl.2020.04.029
M3 - Artículo
C2 - 32917437
SN - 0213-4853
VL - 36
SP - 229
EP - 240
JO - Neurologia
JF - Neurologia
IS - 3
ER -